USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 175 filers reported holding USANA HEALTH SCIENCES INC in Q1 2023. The put-call ratio across all filers is 8.31 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $853 | -5.5% | 14,559 | +1.5% | 0.00% | 0.0% |
| Q2 2023 | $903 | -2.0% | 14,343 | -2.0% | 0.00% | – |
| Q1 2023 | $921 | -5.1% | 14,642 | -19.8% | 0.00% | – |
| Q4 2022 | $970 | -99.5% | 18,254 | +471.5% | 0.00% | – |
| Q3 2022 | $179,000 | -52.8% | 3,194 | -38.9% | 0.00% | – |
| Q2 2022 | $379,000 | -50.0% | 5,224 | -45.3% | 0.00% | -100.0% |
| Q1 2022 | $758,000 | -78.7% | 9,544 | -72.9% | 0.00% | 0.0% |
| Q4 2021 | $3,566,000 | +88.3% | 35,230 | +71.5% | 0.00% | 0.0% |
| Q3 2021 | $1,894,000 | +16.7% | 20,537 | +29.7% | 0.00% | 0.0% |
| Q2 2021 | $1,623,000 | -28.1% | 15,832 | -31.5% | 0.00% | 0.0% |
| Q1 2021 | $2,256,000 | +42.9% | 23,123 | +12.9% | 0.00% | 0.0% |
| Q4 2020 | $1,579,000 | +2.3% | 20,488 | -2.3% | 0.00% | 0.0% |
| Q3 2020 | $1,543,000 | +31.4% | 20,960 | +31.0% | 0.00% | 0.0% |
| Q2 2020 | $1,174,000 | +42.6% | 15,998 | +12.3% | 0.00% | 0.0% |
| Q1 2020 | $823,000 | -50.6% | 14,247 | -32.8% | 0.00% | 0.0% |
| Q4 2019 | $1,666,000 | -1.2% | 21,209 | -14.0% | 0.00% | 0.0% |
| Q3 2019 | $1,687,000 | -12.4% | 24,660 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $1,926,000 | -13.7% | 24,262 | -8.7% | 0.00% | -50.0% |
| Q1 2019 | $2,231,000 | +50.5% | 26,587 | +111.3% | 0.00% | +100.0% |
| Q4 2018 | $1,482,000 | -14.9% | 12,585 | -12.9% | 0.00% | 0.0% |
| Q3 2018 | $1,741,000 | +88.2% | 14,443 | +80.2% | 0.00% | 0.0% |
| Q2 2018 | $925,000 | +3.0% | 8,016 | -23.2% | 0.00% | 0.0% |
| Q1 2018 | $898,000 | +65.4% | 10,443 | +42.3% | 0.00% | – |
| Q4 2017 | $543,000 | +41.8% | 7,338 | +10.8% | 0.00% | – |
| Q3 2017 | $383,000 | -80.0% | 6,621 | -77.8% | 0.00% | -100.0% |
| Q2 2017 | $1,911,000 | +195.8% | 29,816 | +166.2% | 0.00% | +100.0% |
| Q1 2017 | $646,000 | -66.9% | 11,201 | -64.8% | 0.00% | -50.0% |
| Q4 2016 | $1,949,000 | +52.0% | 31,833 | +243.2% | 0.00% | +100.0% |
| Q3 2016 | $1,282,000 | +5.3% | 9,274 | -15.0% | 0.00% | -50.0% |
| Q2 2016 | $1,217,000 | -42.3% | 10,915 | -37.4% | 0.00% | -33.3% |
| Q1 2016 | $2,109,000 | +1119.1% | 17,432 | +1181.8% | 0.00% | – |
| Q4 2015 | $173,000 | -53.4% | 1,360 | -50.9% | 0.00% | – |
| Q3 2015 | $371,000 | +960.0% | 2,768 | +985.5% | 0.00% | – |
| Q2 2015 | $35,000 | +84.2% | 255 | +47.4% | 0.00% | – |
| Q1 2015 | $19,000 | -42.4% | 173 | -46.8% | 0.00% | – |
| Q4 2014 | $33,000 | -45.9% | 325 | -60.4% | 0.00% | – |
| Q3 2014 | $61,000 | -98.4% | 820 | -98.3% | 0.00% | -100.0% |
| Q2 2014 | $3,850,000 | +791.2% | 49,361 | +758.2% | 0.00% | – |
| Q1 2014 | $432,000 | +1293.5% | 5,752 | +1282.7% | 0.00% | – |
| Q4 2013 | $31,000 | -96.1% | 416 | -95.5% | 0.00% | -100.0% |
| Q3 2013 | $800,000 | -23.8% | 9,304 | -35.8% | 0.00% | 0.0% |
| Q2 2013 | $1,050,000 | – | 14,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |